Publicaciones científicas

Dissecting Secondary Immunodeficiency: Identification of Primary Immunodeficiency within B-Cell Lymphoproliferative Disorders

23-oct-2024 | Revista: Journal of Clinical Immunology

María Palacios-Ortega  1   2   3 , Teresa Guerra-Galán  1   2   3 , Adolfo Jiménez-Huete  4 , José María García-Aznar  5 , Marc Pérez-Guzmán  1 , Maria Dolores Mansilla-Ruiz  1   3 , Ángela Villegas Mendiola  1   3 , Cristina Pérez López  5 , Elsa Mayol Hornero  1   2   3 , Alejandro Peixoto Rodriguez  1   2   3 , Ascensión Peña Cortijo  6 , Marta Polo Zarzuela  6 , Marta Mateo Morales  6 , Eduardo Anguita Mandly  6 , Maria Cruz Cárdenas  7 , Alejandra Carrero  2 , Carlos Jiménez García  1 , Estefanía Bolaños  6 , Belén Íñigo  6 , Fiorella Medina  6 , Eduardo de la Fuente  1   2   3 , Juliana Ochoa-Grullón  1   3 , Blanca García-Solís  2   3   8 , Yolanda García-Carmona  9 , Miguel Fernández-Arquero  1   2   3 , Celina Benavente-Cuesta  6 , Rebeca Pérez de Diego  3   8 , Nicholas Rider  10 , Silvia Sánchez-Ramón  11   12   13   14


Abstract

Distinguishing between primary (PID) and secondary (SID) immunodeficiencies, particularly in relation to hematological B-cell lymphoproliferative disorders (B-CLPD), poses a major clinical challenge. We aimed to analyze and define the clinical and laboratory variables in SID patients associated with B-CLPD, identifying overlaps with late-onset PIDs, which could potentially improve diagnostic precision and prognostic assessment.

We studied 37 clinical/laboratory variables in 151 SID patients with B-CLPD. Patients were classified as "Suspected PID Group" when having recurrent-severe infections prior to the B-CLPD and/or hypogammaglobulinemia according to key ESID criteria for PID. Bivariate association analyses showed significant statistical differences between "Suspected PID"- and "SID"-groups in 10 out of 37 variables analyzed, with "Suspected PID" showing higher frequencies of childhood recurrent-severe infections, family history of B-CLPD, significantly lower serum Free Light Chain (sFLC), immunoglobulin concentrations, lower total leukocyte, and switch-memory B-cell counts at baseline. Rpart machine learning algorithm was performed to potentially create a model to differentiate both groups.

The model developed a decision tree with two major variables in order of relevance: sum κ + λ and history of severe-recurrent infections in childhood, with high sensitivity 89.5%, specificity 100%, and accuracy 91.8% for PID prediction. Identifying significant clinical and immunological variables can aid in the difficult task of recognizing late-onset PIDs among SID patients, emphasizing the value of a comprehensive immunological evaluation.

The differences between "Suspected PID" and SID groups, highlight the need of early, tailored diagnostic and treatment strategies for personalized patient management and follow up.

CITA DEL ARTÍCULO  J Clin Immunol. 2024 Oct 23;45(1):32.  doi: 10.1007/s10875-024-01818-2